{'52WeekChange': 0.25226855,
 'SandP52WeekChange': 0.0644362,
 'address1': '31 East 62nd Street',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 6.91,
 'askSize': 1100,
 'averageDailyVolume10Day': 389637,
 'averageVolume': 339626,
 'averageVolume10days': 389637,
 'beta': 0.268347,
 'beta3Year': None,
 'bid': 6.9,
 'bidSize': 1000,
 'bookValue': 1.088,
 'category': None,
 'circulatingSupply': None,
 'city': 'New York',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 7.15,
 'dayLow': 6.86,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -60.647,
 'enterpriseToRevenue': 25.634,
 'enterpriseValue': 484554528,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '212 697 3130',
 'fiftyDayAverage': 6.090857,
 'fiftyTwoWeekHigh': 7.31,
 'fiftyTwoWeekLow': 3.96,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 42999711,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 41,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.33795,
 'heldPercentInstitutions': 0.37704,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/siga.com',
 'longBusinessSummary': 'SIGA Technologies, Inc., a commercial-stage '
                        'pharmaceutical company, focuses on the health '
                        'security and infectious disease markets in the United '
                        'States. Its lead product is TPOXX, an orally '
                        'administered antiviral drug for the treatment of '
                        'human smallpox disease caused by variola virus. The '
                        'company was founded in 1995 and is headquartered in '
                        'New York, New York.',
 'longName': 'SIGA Technologies, Inc.',
 'market': 'us_market',
 'marketCap': 559227072,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_370941',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -17768452,
 'nextFiscalYearEnd': 1640908800,
 'open': 7.08,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '212 672 9100',
 'previousClose': 7.1,
 'priceHint': 2,
 'priceToBook': 6.3419113,
 'priceToSalesTrailing12Months': 29.584404,
 'profitMargins': -0.93999,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 7.15,
 'regularMarketDayLow': 6.86,
 'regularMarketOpen': 7.08,
 'regularMarketPreviousClose': 7.1,
 'regularMarketPrice': 7.08,
 'regularMarketVolume': 280195,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 81047400,
 'sharesPercentSharesOut': 0.0342,
 'sharesShort': 2771895,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 2263589,
 'shortName': 'SIGA Technologies Inc.',
 'shortPercentOfFloat': 0.0514,
 'shortRatio': 7.74,
 'startDate': None,
 'state': 'NY',
 'strikePrice': None,
 'symbol': 'SIGA',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.244,
 'twoHundredDayAverage': 5.4246764,
 'volume': 280195,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.siga.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '10065'}